HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Amplefield’s FY2025 Pivot Slashes Revenue But Boosts Profit

4 Surprising Business Lessons Hidden in a Corporate Financial Report Hidden within the tables of...
SGX-LISTED COMPANIES

Sen Yue Holdings FY2025 S$12M Loss ERASED! See The Shocking New Profit

From S$12 Million in the Red to Black: The Four Surprising Takeaways from Sen...
SGX-LISTED COMPANIES

JUMBO Group FY2025 Profit Plunge – What Triggered The Dramatic Cost Hike?

Jumbo Group's Profits Plunged 37%. So Why Did They Just Announce a Special Dividend? For...
SGX-LISTED COMPANIES

IHH Healthcare Posts Double-Digit Growth For Q3 2025

5 Surprising Takeaways from IHH Healthcare's Latest Earnings Report Look closely at IHH Healthcare’s Q3...
SGX-LISTED COMPANIES

Casa Holdings FY2025 $9.4 Million Swing Explained

We Read a 19-Page Financial Report. Here Are the 4 Most Surprising Takeaways Introduction: We dove...
SGX-LISTED COMPANIES

See How Kimly Built Organizational Resilience In FY2025

More Than Just Kopi: 5 Surprising Strategies Fueling Singapore's Coffee Shop Giant Introduction: The Coffee...
SGX-LISTED COMPANIES

Profit Vanishes! What Hit OneApex In FY2025?

From S76 Million to S50 Thousand: 4 Shocking Truths Buried in One Company's Financial...
SGX-LISTED COMPANIES

Thai Beverage Reports Mixed FY25

4 Surprising Takeaways From ThaiBev's FY2025 Financials Introduction: At first glance, Thai Beverage's financial year 2025...
SGX-LISTED COMPANIES

The FY2025 Profit Puzzle At Envictus International Revealed

Envictus Grew Its Revenue by 8.4%—So Why Did Its Profits Plunge by 40%? 5...
SGX-LISTED COMPANIES

Net Pacific Financial’s Q1 2026 Diversification Strategy Is Failing

3 Hard-Earned Lessons From a Company's Painful Pivot Introduction: Every company chases growth, often by diversifying...
SGX-LISTED COMPANIES

BRC Asia Hits Record Net Profit In FY2025

5 Key Insights from BRC Asia's Record-Breaking Year Introduction: Beyond the headline of a record-breaking net...
SGX-LISTED COMPANIES

GDS Global Returns To Profitability In FY2025

From a S$2.3 Million Loss to Profit: 5 Key Insights from GDS Global's Remarkable...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...